It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Bacteroidales (syn. Bacteroidetes) are prominent members of the human gastrointestinal ecosystem mainly due to their efficient glycan-degrading machinery, organized into gene clusters known as polysaccharide utilization loci (PULs). A single PUL was reported for catabolism of high-mannose (HM) N-glycan glyco-polypeptides in the gut symbiont Bacteroides thetaiotaomicron, encoding a surface endo-β-N-acetylglucosaminidase (ENGase), BT3987. Here, we discover an ENGase from the GH18 family in B. thetaiotaomicron, BT1285, encoded in a distinct PUL with its own repertoire of proteins for catabolism of the same HM N-glycan substrate as that of BT3987. We employ X-ray crystallography, electron microscopy, mass spectrometry-based activity measurements, alanine scanning mutagenesis and a broad range of biophysical methods to comprehensively define the molecular mechanism by which BT1285 recognizes and hydrolyzes HM N-glycans, revealing that the stabilities and activities of BT1285 and BT3987 were optimal in markedly different conditions. BT1285 exhibits significantly higher affinity and faster hydrolysis of poorly accessible HM N-glycans than does BT3987. We also find that two HM-processing endoglycosidases from the human gut-resident Alistipes finegoldii display condition-specific functional properties. Altogether, our data suggest that human gut microbes employ evolutionary strategies to express distinct ENGases in order to optimally metabolize the same N-glycan substrate in the gastroinstestinal tract.
The human gut microbiome has a substantial impact on human health. Here, the authors find that prominent human gut microbes express functionally distinct surface endo-β-N-acetylglucosaminidases encoded by different polysaccharide utilization loci to optimally metabolize the same oligomannose N-glycan substrate in the gastrointestinal tract.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Emory University School of Medicine, Department of Biochemistry, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
2 Emory University School of Medicine, Department of Biochemistry, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502); National Institute of Dental and Craniofacial Research (NIDCR/NIH), Structural Biochemistry Unit, Bethesda, USA (GRID:grid.419633.a) (ISNI:0000 0001 2205 0568)
3 University of São Paulo, Institute of Physics (IFSC-USP), São Carlos, Brazil (GRID:grid.11899.38) (ISNI:0000 0004 1937 0722); Cornell University, Center for Innovative Proteomics, Ithaca, USA (GRID:grid.5386.8) (ISNI:0000 0004 1936 877X)
4 Emory University School of Medicine, Department of Biochemistry, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502); The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health, Camperdown, Australia (GRID:grid.1013.3) (ISNI:0000 0004 1936 834X)
5 University of the Basque Country, Instituto Biofisika (UPV/EHU, CSIC), Leioa, Spain (GRID:grid.11480.3c) (ISNI:0000 0001 2167 1098)
6 Emory University School of Medicine, Department of Pediatrics, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
7 Biobizkaia Health Research Institute, Structural Glycoimmunology Laboratory, Barakaldo, Spain (GRID:grid.189967.8); Basque Foundation for Science, Ikerbasque, Bilbao, Spain (GRID:grid.424810.b) (ISNI:0000 0004 0467 2314)
8 Tower R, Structural Glycobiology Laboratory, Department of Structural and Molecular Biology, Molecular Biology Institute of Barcelona (IBMB), Spanish National Research Council (CSIC), Barcelona Science Park, c/Baldiri Reixac 4-8, Barcelona, Spain (GRID:grid.428973.3) (ISNI:0000 0004 1757 9848)